InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Sjuts Dustin S, Chief Executive Officer. Director active across 1 companies, notably Revance Therapeutics, Inc.. Aggregated, 8 filings have been recorded. The latest transaction was disclosed on 15 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
€26,4771,835 shares@ €14.429126.0% of flow
Common Stock
SEC:0001209191-22-019707:0·
€25,1972,134 shares@ €11.807524.7% of flow
Common Stock
SEC:0001479290-22-000025:0·
€7,252513 shares@ €14.13728.8% of flow
Common Stock
SEC:0001479290-21-000175·
€7,252513 shares@ €14.1377.1% of flow
Common Stock
SEC:0001479290-21-000175:0·
035,920 shares0
Common Stock
SEC:0001479290-21-000167·
035,920 shares0
Common Stock
SEC:0001479290-21-000167:0·
€17,919882 shares@ €20.316771.2% of flow
Common Stock
SEC:0001479290-21-000134·
€17,919882 shares@ €20.316717.6% of flow
Common Stock
SEC:0001479290-21-000134:0·
8 of 8 declarations
About Sjuts Dustin S
Dustin S. Sjuts is the CEO and President of Revance Therapeutics, Inc. In this role, he is responsible for the overall management of the company and the implementation of its strategy. Revance Therapeutics, Inc. is an innovative biopharmaceutical company. Dustin leverages his expertise to lead the company towards sustainable growth and strengthen its market position.
